EMILY BARVINCHAK: Open Payments
NPI 1356918700 · VESTAL, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,141 in 148 payments from 30 companies in 2025. Trend: 2023 $1,478 · 2024 $3,197 · 2025 $4,141
Food & beverage: $3,499Travel & lodging: $642
| Company | Payments | Amount |
|---|---|---|
| LivaNova USA, Inc. | 9 | $1,109 |
| ABBVIE INC. | 56 | $688 |
| EMD Serono, Inc. | 15 | $500 |
| Abbott Laboratories | 8 | $407 |
| UCB, Inc. | 9 | $217 |
| SK Life Science, Inc. | 6 | $145 |
| SPR Therapeutics, Inc | 1 | $96 |
| Lundbeck LLC | 4 | $94 |
| Vanda Pharmaceuticals Inc. | 3 | $74 |
| Lilly USA, LLC | 4 | $73 |
Products named: VNS Therapy, INFINITY, UBRELVY, QULIPTA, Mavenclad, VNS THERAPY SENTIVA MODEL 1000 GENERATOR, SPRINT PNS System, VYEPTI.
Industry payments across NY — which companies pay providers there.
